FIELD: medicine.
SUBSTANCE: pharmaceutical composition of taxan for introduction to a mammal, preferentially to people, contains two compositions combined before introduction to form a no-slump clear solution. First of said compositions represents a solid composition of dried taxan not containing surface-active substances, oils, polymers, solubilising agents, preservatives and excipients. Second of said compositions represents a solubilising composition for said solid composition of dried taxan which contains at least one polymer nonionic surface-active substance and water with the absence of an organic solvent. Said composition does not contain Polysorbate 80 and polyoxyethylated castor oil. A method of producing the solid composition is implemented by freeze-drying of taxan in a drying organic solvent. A kit for said composition of taxan for injections contains a pre-filled syringe. Also, there is offered a pharmaceutical solution of taxan for perfusion not containing the organic solvent.
EFFECT: composition of taxan according to the invention provides maintaining shelf-life stability without required storage in the cooling conditions, facilitates preparation for infusion manipulations.
30 cl, 6 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TAXANES AND METHODS FOR TREATMENT USING THEREOF | 1999 |
|
RU2236226C2 |
AMORPHOUS SOLID DISPERSION COMPRISING TAXANE, TABLET COMPRISING SAME, AND METHOD FOR PREPARING SAME | 2015 |
|
RU2684632C2 |
PHARMACEUTICAL COMPOSITION CONTAINING TAXAN DERIVATIVE AND USED FOR PREPARATION OF INFUSION SOLUTION, METHOD FOR PREPARATION AND APPLICATION | 2007 |
|
RU2398578C2 |
MICELLAR COMPOSITION OF AMPHIPHILIC BLOCK COPOLYMER CONTAINING TAXANE AND METHOD FOR PREPARING IT | 2008 |
|
RU2449785C2 |
TAXAN PARTICLES AND THEIR APPLICATION | 2016 |
|
RU2750163C2 |
COMBINED THERAPY WITH COMPOSITIONS OF TAXANE NANOPARTICLES AND HEDGEHOG INHIBITORS | 2010 |
|
RU2561055C2 |
PHARMACEUTICAL COMPOSITION FOR ORAL ADMISSION CONTAINING TAXAN | 2015 |
|
RU2683326C2 |
COMPOSITIONS, INCLUDING POORLY SOLUBLE IN WATER PHARMACEUTIC SUBSTANCES AND ANTIMICROBIAL SUBSTANCES | 2006 |
|
RU2433818C2 |
STABLE EMULSION FOR PARENTERAL INTRODUCTION OF BADLY SOLUBLE IN WATER COMPOUNDS, WHICH HAVE ANTI-TUMOR ACTIVITY, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2370261C2 |
TAXANES, PHARMACEUTICAL COMPOSITIONS, INHIBITION METHOD | 2001 |
|
RU2265019C2 |
Authors
Dates
2011-09-27—Published
2007-01-18—Filed